Nanjing, China

Sheng Chen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: L&p Food Ingredient Co., Ltd, Langnai Biotech Co., Ltd. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheng Chen. Retrieved from https://idiyas.com/inventor/sheng-chen-hr27xdcy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sheng Chen

Introduction

Sheng Chen is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on enzymes.

Latest Patents

Sheng Chen holds a patent for a 3-epimerase and the polynucleotide encoding the same. This patent includes a 3-epimerase, an encoding polynucleotide, a nucleic acid construct, a vector, and a host cell comprising the polynucleotide. Additionally, it outlines a method for producing the 3-epimerase and its various uses.

Career Highlights

Throughout his career, Sheng Chen has worked with prominent companies such as Langnai Biotech Co., Ltd and L&P Food Ingredient Co., Ltd. His work in these organizations has contributed to advancements in food technology and biotechnology.

Collaborations

Sheng Chen has collaborated with notable colleagues, including Shilei Han and Zhilin Zhang. Their combined expertise has fostered innovation in their respective fields.

Conclusion

Sheng Chen's contributions to biotechnology through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…